ArticleCell death & disease2019

NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma.

Xiao-Ping Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.